| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8468373bcd310a67844741b1cb2ba20d |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6923
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0087 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-48 |
| filingDate |
2000-10-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7bda7861cb92763bf8c2dc249cfe5b83
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_914c585084fc707cace11abca391a027 |
| publicationDate |
2004-08-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-1449523-A1 |
| titleOfInvention |
Composition and method for stable injectable liquids |
| abstract |
The invention deals with the problem of stabilizing vaccines so that they can bentransported as an injectable liquid without refrigeration. The vaccine, or othernbioactive material is stabilized in a glassy substance, small particles of which arensuspended in a perfluorocarbon liquid. The resulting mixture remains as ansuspension in which the active ingredient is preserved and which can be injectedndirectly into a patient. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10821210-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-2498774-A |
| priorityDate |
2000-10-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |